Reduced cerebral injury in CRH-R1 deficient mice after focal ischemia: A potential link to microglia and atrocytes that express CRH-R1

Journal of Cerebral Blood Flow and Metabolism

Volumn 23, Issue 10, 2003, Pages 1151-1159

  Stevens, Susan L ^a   Shaw, Tatyana E ^a   Dykhuizen, Emily ^a   Lessov, Nikola S ^a   Hill, Jennifer K ^a   Wurst, Wolfgang ^b   Stenzel Poore, Mary P ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Astrocytes; CRH; CRH R1; Ischemia; Microglia

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; CYCLIC AMP; EXCITOTOXIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN INJURY; BRAIN ISCHEMIA; CONTROLLED STUDY; INFLAMMATION; KNOCKOUT MOUSE; MICROGLIA; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROKE;

EID: 0141925701     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.WCB.0000086957.72078.D4     Document Type: Article

References (67)

1. Agelaki S, Tsatsanis C, Gravanis A, Margioris AN (2002) Corticotropin-releasing hormone augments proinflammatory cytokine production from macrophages in vitro and in lipopolysaccharide-induced endotoxin shock in mice. Infect Immun 70:6068-6074
2. Baigent SM (2001) Peripheral corticotropin-releasing hormone and urocortin in the control of the immune response. Peptides 22:809-820
3. Baram T, Chalmers D, Chen C, Koutsoukos Y, Souza ED (1997) The CRF1 receptor mediates the excitatory actions of corticotropin releasing factor (CRF) in the developing rat brain: in vivo evidence using a novel, selective, non-peptide CRF receptor antagonist. Brain Res 770:89-95
4. Baram TZ, Hatalski CG (1998) Neuropeptide-mediated excitability: a key triggering mechanism for seizure generation in the developing brain. Trends Neurosci 21:471-476
5. Baram TZ, Ribak CE (1995) Peptide-induced infant status epilepticus causes neuronal death and synaptic reorganization. Neuro Reports 6:277-280
6. Barone F, Feuerstein G (1999) Inflammatory mediators and stroke: new opportunities for novel therapeutics. J Cereb Blood Flow Metab 19:819-834
7. Beamer N, Coull B, Clark W, Hazel J, Silberger J (1995) Interleukin-6 and interleukin-1 receptor antagonist in acute stroke. Ann Neurol 37:800-805
8. Beavo JA, Rogers NL, Crofford OB, Hardman JG, Sutherland EW, Newman EV (1970) Effects of xanthine derivatives on lipolysis and on adenosine 3′,5′-monophosphate phosphodiesterase activity. Mol Pharmacol 6:597-603
9. Bederson J, Pitts L, Germano S, Nishimura M, Davis R, Bartowski H (1986) Evaluation of 2,3,5-triphenyhetrazoline chloride as a stain for detection of quantification of experimental cerebral infarction in rats. Stroke 17:1304-1308
10. Bishop GA, King JS (1992) Differential modulation of Purkinje cell activity by enkephalin and corticotropin releasing factor. Neuropeptides 22:167-174
11. Bishop GA, Seelandt CM, King JS (2000) Cellular localization of corticotropin relesing factor receptors in the adult mouse cerebellum. Neuroscience 101:1083-1092
12. Brar BK, Jonassen AK, Stephanou A, Santilli G, Railson J, Knight RA, Yellon DM, Latchman DS (2000) Urocortin protects against ischemic and reperfusion injury via a MAPK-dependent pathway. J Biol Chem 275:8508-8514
13. Brar BK, Stephanou A, Okosi A, Lawrence KM, Knight RA, Marber MS, Latchman DS (1999) CRH-like peptides protect cardiac myocytes from lethal ischemic injury. Mol Cell Endocrinol 158:55-63
14. Chalmers DT, Lovenberg TW, DeSouza EB (1995) Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J Neurosci 15:6340-6350
15. Chen Y, Brunson K, Muller M, Cariga W, Bram T (2000) Immunocytochemical distribution of corticotropin-releasing hormone receptor type-1 (CRF1)-like immunoreactivity in the mouse brain: Light microscopy analysis using an antibody directed against the c-terminus. J Comp Neurol 420:305-323
16. Choi D-I, Park S-K, Kim HS, Seo M-O, Kim S-J, Kim J-S, Won MH, Kang T-C (2001) Expression of corticotropin releasing factor, but not its binding protein, in CA1 pyramidal cells of gerbil hippocampus following tranisient ischemia. Brain Res 899:255-259
17. Clark W, Lauten J, Lessov N, Woodward W, Coull B (1995) The influence of antiadhesion therapies on leukocyte subset accumulation in central nervous system ischemia in rats. J Mol Neurosci 6:43-50
18. Clark WM, Lessov NS, Dixon MP, Eckenstein F (1997) Monofilament intraluminal middle cerebral artery occlusion in the mouse. Neurol Res 19:641-648
19. Coste SC, Kesterson RA, Heldwein KA, Stevens SL, Hill JK, Heard AD, Hollis JH, Murray SE, Pantely GA, Hohimer AR, Hatton DC, Phillips TJ, Finn DA, Low MJ, Rittenberg MB, Stenzel P, Stenzel-Poore MP (2000) Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2. Nature Genet 24:403-409
20. Craighead MW, Boutin H, Middlehurst KML, Allan SM, Brooks N, Kimber I, Rothwell NJ (2000) Influence of corticotrophin releasing factor on neuronal cell death in vitro and in vivo. Brain Res 881:139-143
21. Crofford LJ, Sano H, Karalis K, Friedman TC, Epps HR, Remmers EF, Mathern P, Chrousos GP, Wilder RL (1993) Corticotropin-releasing hormone in synovial fluids and tissues of patients with rheumatoid arthritis and osteoarthritis. J Immunol 151:1587-1596
22. Crofford LJ, Sano H, Karalis K, Webster EL, Goldmuntz EA, Chrousos GP, Wilder RL (1992) Local secretion of corticotropin-releasing hormone in the joints of Lewis rats with inflammatory arthritis. J Clin Invest 90:2555-2564
23. DeGraba TJ (1998) The role of inflammation after acute stroke: utility of pursuing anti-adhesion molecule therapy. Neurology 51:S62-68
24. Etienne-Manneville S, Chaverot N, Strosberg AD, Couraud P (1999) ICAM-1-coupled signaling pathways in astrocytes converge to cyclic AMP response element-binding protein phosphorylation and TNF-α secretion. J Immunol 163:668-674
25. Fisher LA (1989) Corticotropin-releasing factor: endocrine and autonomic integration of responses to stress. Trends Pharmacol Sci 10:189-193
26. Giulian D, Baker T (1986) Characterization of ameboid microglia isolated from developing mammalian brain. J Neurosci 6:2163-2178
27. Giulian D, Vaca K, Corpuz M (1993) Brain glia release factors with opposing actions upon neuronal survival. J Neurosci 13:29-37
28. Grammatopoulos DK, Randeva HS, Levine MA, Kanellopoulou KA, Hillhouse EW (2001) Rat cerebral cortex corticotropin-releasing hormone receptors: evidence for receptor coupling to multiple G-proteins. J Neurochem 76:509-519
29. Gregersen R, Lambertsen K, Finsen B (2000) Microglia and macrophages are the major source of tumor necrosis factor in permanent middle cerebral artery occlusion in mice. J Cereb Blood Flow Metab 20:53-65
30. Grogaard B, Schurer L, Gerdin B, Arfors K (1989) Delayed hypoperfusion after incomplete forebrain ischemia in the rat. The role of polymorphonuclear leukocytes. J Cereb Blood Flow Metab 9:500-505
31. Hargreaves KM, Costello AH, Joris JL (1989) Release from inflamed tissue of a substance with properties similar to corticotrophin-releasing factor. Neuroendocrinology 49:476-482
32. Heldwein KA, Redick DL, Rittenberg MB, Claycomb WC, Stenzel-Poore MP (1996) Corticotropin-releasing hormone receptor expression and functional coupling in neonatal cardiac myocytes and AT-1 cells. Endocrinology 137:3631-3639
33. Hill J, Gunion-Rinker L, Kulhanek D, Lessov N, Kim S, Clark W, Nishi R, Stenzel-Poore M, Eckenstein F (1999) Temporal modulation of cytokine expression following focal cerebral ischemia in mice. Brain Res 820:45-54
34. Kageyama K, Bradbury M, Zhao L, Blount AL, Vale WW (1999) Urocortin messenger ribonucleic acid: tissue distribution in the rat and regulation in thymus by lipopolysaccharide and glucocorticoids. Endocrinology 140:5651-5658
35. Kapcala LP, Weng C-F (1992) In vitro regulation of immunoreactive β-endorphin secretion from adult and fetal hypothalamus by sequential stimulation with corticotropin-releasing hormone. Brain Res 588:13-20
36. Karalis K, Sano H, Redwine J, Listwak S, Wilder RL, Chrousos GP (1991) Autocrine or paracrine inflammatory actions of corticotrophin-releasing hormone in vivo. Science 254:421-423
37. Karteris E, Grammatopoulos D, Randeva H, Hillhouse EW (2000) Signal transduction characteristics of the corticotropin-releasing hormone receptors in the feto-placental unit. J Clin Endocrinol Metab 85:1989-1996
38. Kiang J (1997) Corticotropin-releasing factor-like peptides increase cytosolic [Ca2+] in human epidermoid A-431 cells. Eur J Pharm 329:237-244
39. Kiang JG (1994) Corticotropin-releasing factor increases [Ca2+] via receptor mediated Ca2+ channels in human epidermoid A-431 cells. Eur J Pharm 267:135-142
40. Kohno M, Kawahito Y, Tsubouchi Y, Hashiramoto A, Yamada R, Inoue KI, Kusaka Y, Kubo T, Elenkov IJ, Chrousos GP, Kondo M, Sano H (2001) Urocortin expression in synovium of patients with rheumatoid arthritis and osteoarthritis: relation to inflammatory activity. J Clin Endocrinol Metab 86:4344-4352
41. Lee J, Grabb MC, Zipfel GJ, Choi DW (2000a) Brain tissue responses to ischemia. J Clin Invest 106:723-731
42. Lee SJ, Drabik K, Wagoner NJV, Lee S, Choi C, Dong Y, Benveniste EN (2000b) ICAM-1 induced expression of proinflammatory cytokines in astrocytes: involvement of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways. J Immunol 165:4658-4666
43. Leu SJ, Singh VK (1992) Stimulation of interleukin 6 production by corticotropin releasing factor. Cell Immunol 143:220-227
44. Lewis K, Li C, Perrin MH, Blount A, Kunitake K, Donaldson C, Vaughan J, Reyes TM, Gulyas J, Fischer W, Bilezikjian L, Rivier J, Sawchenko PE, Vale WW (2001) Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc Natl Acad Sci U S A 98:7570-7575
45. Lezoualc'h F, Engert S, Berning B, Behl C (2000) Corticotropin-releasing hormone-mediated neuroprotection against oxidative stress is associated with the increased release of non-amyloidogenic amyloid β precursor protein and with suppression of nuclear factor-κB. Mol Endocrinol 14:147-159
46. Loddick S, Turnbull A, Rothwell N (1998) Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat. J Cereb Blood Flow Metab 18:176-179
47. Lovenberg TW, Chalmers DT, Liu C, DeSouza EB (1995) CRF2α and CRF2β receptor mRNAs are differentially distributed between the rat central nervous system and the peripheral tissues. Endocrinology 136:4139-4142
48. Lyons MK, Anderson RE, Meyer FB (1991) Corticotropin releasing factor antagonist reduces ischemic hippocampal neuronal injury. Brain Res 545:339-342
49. Mackay KB, Bozigian H, Grigoriadis DE, Loddick SA, Verge G, Foster AC (2001) Neuroprotective effects of the CRF1 antagonist R121920 after permanent focal ischemia in the rat. J Cereb Blood Flow Metab 21:1208-1214
50. Maecker H, Desai A, Dash R, Rivier J, Vale W, Sapolsky R (1997) Astressin, a novel and potent CRF antagonist, is neuroprotective in the hippocampus when administered after a seizure. Brain Res 744:166-170
51. Mastorakos G, Bouzas EA, Silver PB, Sartani G, Friedman TC, Chan C, Caspi RR, Chrousos G (1995) Immune corticotropin-releasing hormone is present in the eyes of and promotes experimental autoimmune uveoretinitis in rodents. Endocrinology 136:4650-4658
52. McMillian MK, Thai L, Hong J-S, O'Callaghan JP, Pennypacker KR (1994) Brain injury in a dish: a model for reactive gliosis. Trends Neurosci 17:138-142
53. Owens M, Nemeroff C (1991) Physiology and pharmacology of corticotropin-releasing factor. Pharmacol Rev 43:425-471
54. Peckham I, Sobel S, Comer J, Jaenisch R, Barklis E (1989) Retrovirus activation in embryonal carcinoma cells by cellular promoters. Genes Dev 3:2062-2071
55. Pedersen WA, McCullers D, Culmsee C, Haughey NJ, Herman JP, Mattson MP (2001) Corticotropin-releasing hormone protects neurons against insults relevant to the pathogenesis of Alzheimer's Disease. Neurobiol Dis 8:492-503
56. Pedersen WA, Wan R, Zhang P, Mattson MP (2002) Urocortin, but not urocortin II, protects cultured hippocampal neurons from oxidative and excitotoxic cell death via corticotropin-releasing hormone receptor type I. J Nerosci 22:404-412
57. Pereda MP, Sauer J, Castro CP, Finkielman S, Stalla GK, Holsboer F, Arzt E (1995) Corticotropin-releasing hormone differentially modulates the interleukin-1 system according to the level of monocyte activation by endotoxin. Endocrinology 136:5504-5510
58. Reyes T, Lewis K, Perrin M, Kunitake K, Vaughan J, Arias C, Hogenesch J, Gulyas J, Rivier J, Vale W, Sawchenko P (2001) Urocortin II: A member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc Natl Acad Sci U S A 98:2843-2848
59. Schulte HM, Bamberger CM, Elsen H, Herrmann G, Bamberger AM, Barth J (1994) Systemic interleukin-1 and interleukin-2 secretion in response to acute stress and to corticotropin releasing hormone in humans. Eur J Clin Invest 24:773-777
60. Stevens S, Bao J, Hollis J, Lessov NS, Clark WM, Stenzel-Poore M (2002) The use of flow cytometry to evaluate temporal changes in inflammation. Brain Res 932:110-119
61. Strijbos PJ, Relton JK, Rothwell NJ (1994) Corticotropin-releasing factor antagonist inhibits damage induced by focal cerebral ischemia or activation of NMDA receptors in the rat brain. Brain Res 656:405-408
62. Takuma K, Matsuda T, Yoshikawa T, Kitanaka J, Gotoh M, Hayata K, Baba A (1994) Corticotropin-releasing factor stimulates Ca2+ influx in cultured rat astrocytes. Biochem Biophys Res Comm 199:1103-1107
63. Timpl P, Spanagel R, Sillaber I, Kresse A, Reul JM, Stalla GK, Blanquet V, Steckler T, Holsboer F, Wurst W (1998) Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor. Nature Genet 19:162-166
64. Vaughan J, Donaldson C, Lewis K, Sutton S, Chan R, Turnbull AV, Lovejoy D, Rivier C, Rivier J, Sawchenko PE, Vale W (1995) Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 378:287-292
65. Venihaki M, Dikkes P, Carrigan A, Karalis KP (2001) Corticotropin-releasing hormone regulates IL-6 expression during inflammation. J Clin Invest 108:1159-1166
66. Wong ML, Loddick SA, Bongiorno PB, Gold PW, Rothwell NJ, Lucino J (1995) Focal cerebral ischemia induces CRH mRNA in rat cerebral cortex and amygdala. Molec Neurosci 6:1785-1788
67. Yatsushiro K, Chalmers DT, Loddick SA, De Souza EB, Graham DI, McCulloch J (1997) The involvement of corticotrophin releasing factor (CRF) in focal cerebral ischemia. J Cereb Blood Flow Metab 17:S533